Professor Beth Psaila: Platelets are Acting as Sentinels in the Blood
Cancer Research UK (CRUK) shared a post on LinkedIn:
“Can the blood’s natural clean-up system help us detect cancer earlier?
Seven years ago, we gave Professor Beth Psaila funding to find out. Now, she’s uncovered a potentially transformative insight.
Psaila‘s team have found that platelets, best known for their role in clotting, also act as biological scavengers. They move through the bloodstream sucking up fragments of DNA, including those released by cancer cells.
It’s a discovery that could make liquid biopsies even more sensitive and effective for early detection. With a modest adjustment to how blood samples are processed, we may be able to harness platelets to detect cancer at its earliest stages, when treatment is most likely to succeed.
“Platelets are acting as sentinels in the blood,” explains Professor Psaila. “They have a unique ability to hoover up things they encounter.”
This research opens new avenues for innovation in early cancer detection and exemplifies how fundamental science can lead to life-saving clinical applications.
Find out more in the article here”

Stay updated with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
